Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease

October 25, 2022 updated by: Rhode Island Hospital

Development of a Personalized Intervention to Motivate Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease

Modifying health behaviors like physical activity level, diet, stress, and mental activity level can lower risk for Alzheimer's disease, but many middle-aged and older adults find it difficult to sustain health behavior changes over the long term. This project will develop a new intervention that educates people about Alzheimer's disease risk factors and helps them understand how their personal health beliefs may prevent them from making long-lasting lifestyle changes. The goal is to help people sustain health behavior changes to prevent or delay the onset of Alzheimer's disease and related dementias.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 69 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 45-69 years
  • normal cognition (Minnesota Cognitive Acuity Scale > 52)
  • English language fluency
  • at least two of the following: i) BMI > 24.9; ii) systolic blood pressure > 125 mmHg; iii) LDL cholesterol > 115 mg/dL; iv) HbA1C > 6.0%; v) at least one APOE ε4 allele; vi) first-degree relative with AD.

Exclusion Criteria:

  • history of serious mental illness (i.e., schizophrenia, bipolar disorder)
  • history of neurologic or neurodevelopmental disorder
  • current alcohol or drug use disorder based on self-report
  • current enrollment in an AD prevention clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Healthy Living Education
The basic healthy living education intervention is a 24-session program (two sessions/week for 12 weeks) designed to educate participants about major modifiable risk factors for Alzheimer's disease. The first session each week is didactic, intended to increase knowledge about each Alzheimer's disease risk factor. The second session involves repetition and practice of didactic material as well as strategizing cues to action
24-session healthy living education program
EXPERIMENTAL: Enhanced Healthy Living Education
The enhanced healthy living education intervention will include the same didactic content as the basic HLE course for the first session each week. The second session will focus on personal health beliefs and how they affect specific health behaviors. This may include discussing perceived benefits, troubleshooting barriers to action, making specific action plans, and implementing natural reward systems to bolster self-efficacy.
24-session healthy living education program, with enhanced content about health beliefs and mechanisms of behavior change

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Threat of Alzheimer's Disease Scale
Time Frame: baseline
7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat
baseline
Perceived Threat of Alzheimer's Disease Scale
Time Frame: 4 weeks
7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat
4 weeks
Perceived Threat of Alzheimer's Disease Scale
Time Frame: 8 weeks
7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat
8 weeks
Perceived Threat of Alzheimer's Disease Scale
Time Frame: 12 weeks (treatment endpoint)
7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat
12 weeks (treatment endpoint)
Dementia Awareness Questionnaire
Time Frame: baseline
self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness
baseline
Dementia Awareness Questionnaire
Time Frame: 4 weeks
self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness
4 weeks
Dementia Awareness Questionnaire
Time Frame: 8 weeks
self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness
8 weeks
Dementia Awareness Questionnaire
Time Frame: 12 weeks
self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness
12 weeks
Generalized Self-Efficacy Scale
Time Frame: baseline
10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy
baseline
Generalized Self-Efficacy Scale
Time Frame: 4 weeks
10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy
4 weeks
Generalized Self-Efficacy Scale
Time Frame: 8 weeks
10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy
8 weeks
Generalized Self-Efficacy Scale
Time Frame: 12 weeks
10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mediterranean Diet Assessment Tool
Time Frame: baseline
14-item measure of adherence to a Mediterranean type diet; higher scores indicate greater diet adherence
baseline
Mediterranean Diet Assessment Tool
Time Frame: 12 weeks
14-item measure of adherence to a Mediterranean type diet; higher scores indicate greater diet adherence
12 weeks
CHAMPS Activities Questionnaire for Older Adults
Time Frame: baseline
self-report measure of engagement in physical activities, tailored to older adult population; higher scores indicate greater engagement in physical activity
baseline
CHAMPS Activities Questionnaire for Older Adults
Time Frame: 12 weeks
self-report measure of engagement in physical activities, tailored to older adult population; higher scores indicate greater engagement in physical activity
12 weeks
Florida Cognitive Activities Scale
Time Frame: baseline
25-item self-report measure about engagement in mentally stimulating activities; higher scores indicate greater cognitive activity
baseline
Florida Cognitive Activities Scale
Time Frame: 12 weeks
25-item self-report measure about engagement in mentally stimulating activities; higher scores indicate greater cognitive activity
12 weeks
Perceived Stress Scale
Time Frame: baseline
10-item measure that assesses perceived stress; higher scores indicate greater perceived stress
baseline
Perceived Stress Scale
Time Frame: 4 weeks
10-item measure that assesses perceived stress; higher scores indicate greater perceived stress
4 weeks
Perceived Stress Scale
Time Frame: 8 weeks
10-item measure that assesses perceived stress; higher scores indicate greater perceived stress
8 weeks
Perceived Stress Scale
Time Frame: 12 weeks
10-item measure that assesses perceived stress; higher scores indicate greater perceived stress
12 weeks
Positive and Negative Affect Schedule
Time Frame: baseline
20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively
baseline
Positive and Negative Affect Schedule
Time Frame: 4 weeks
20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively
4 weeks
Positive and Negative Affect Schedule
Time Frame: 8 weeks
20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively
8 weeks
Positive and Negative Affect Schedule
Time Frame: 12 weeks
20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

April 1, 2023

Primary Completion (ANTICIPATED)

April 30, 2024

Study Completion (ANTICIPATED)

April 30, 2024

Study Registration Dates

First Submitted

October 19, 2022

First Submitted That Met QC Criteria

October 25, 2022

First Posted (ACTUAL)

October 31, 2022

Study Record Updates

Last Update Posted (ACTUAL)

October 31, 2022

Last Update Submitted That Met QC Criteria

October 25, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

Clinical Trials on Basic Healthy Living Education

3
Subscribe